Stroke, also known as cerebrovascular accident (CVA), is a medical condition that occurs when the blood supply to the brain is disrupted, causing brain tissue to ischemia or infarction.
Cerebrovascular accidents can be ischaemia or infarction of the brain tissue secondary to a disrupted blood supply (ischaemic stroke), intracranial haemorrhage, with bleeding in or around the brain (haemorrhagic stroke), or a combination of both (mixed stroke).
Common symptoms of stroke include limb weakness, facial weakness, dysphasia (speech disturbance), visual field defects, sensory loss, ataxia and vertigo (posterior circulation infarction).
The combined contraceptive pill carries a tiny increased risk of stroke, with a higher risk in patients with migraines with aura, smokers over 34 years or those with a history of stroke or TIA.
Surgical interventions are considered where there is significant carotid artery stenosis and the options are carotid endarterectomy, angioplasty and stenting.
Patients with a TIA or stroke are investigated for carotid artery stenosis and atrial fibrillation with carotid imaging, ECG or ambulatory ECG monitoring, and anticoagulation is initiated for atrial fibrillation after excluding haemorrhage and finishing two weeks of aspirin.
Thrombectomy is considered in patients with a confirmed blockage of the proximal anterior circulation or proximal posterior circulation and may be considered within 24 hours of the symptom onset and alongside IV thrombolysis.
Stroke patients require a period of adjustment and rehabilitation involving a multi-disciplinary team of stroke physicians, nurses, speech and language (SALT) to assess swallowing, dieticians in those at risk of malnutrition, physiotherapy, occupational therapy, social services, optometry and ophthalmology, psychology, orthotics, and more.
Management of stroke involves excluding hypoglycaemia, immediate CT brain to exclude haemorrhage, aspirin 300mg daily for two weeks, admission to a specialist stroke centre, and thrombolysis with alteplase once haemorrhage is excluded.
Patients with a stroke need close monitoring for complications, particularly intracranial or systemic haemorrhage, with access to immediate imaging if bleeding is suspected.
Alteplase is a tissue plasminogen activator that rapidly breaks down clots and may be given within 4.5 hours of the symptom onset, based on local protocols and by an appropriately trained team.
In patients with an ischaemic stroke, lowering the blood pressure can worsen the ischaemia and high blood pressure treatment is only indicated in hypertensive emergency or to reduce the risks when giving intravenous thrombolysis.